Our Science: Publications

- KARA E, DUPUY L, BOUILLON C, CASTERET S, MAUREL MC, 2019

"Modulation of Gonadotropins Activity by Antibodies"

Front Endocrinol (Lausanne). 2019 Feb 18:10:15.

​

​

- ULLOA-AGUIRRE A, CRÉPIEUX P, POUPON A, MAUREL MC, REITER E, 2011

Novel pathways in gonadotropin receptor signaling and biased agonism.

Rev Endocr Metab Disord, 2011 Dec; 12(4):259-74.

​

​

- WEHBI V, TRANCHANT T, DURAND G, MUSNIER A, DECOURTYE J, PIKETTY V, BUTNEV VY, BOUSFIELD GR, CRÉPIEUX P, MAUREL MC, REITER E, 2010. 

Partially deglycosylated equine LH preferentially activates beta-arrestin-dependent signaling at the follicle-stimulating hormone receptor.

Mol Endocrinol. 2010 Mar; 24(3):561-73.

​

​

- HERVE V, ROY F, BERTIN J, GUILLOU F, MAUREL MC, 2004 

Anti-eCG antibodies generated in goats treated with eCG for the induction of ovulation modulate the LH and FSH bioactivities of eCG differently.

Endocrinology, 145 : 294-303.

​

​

- MAUREL MC, ROY F, HERVE V, BERTIN J, VAIMAN D, CRIBIU E, MANFREDI E, BOUVIER F, LANTIER I, BOUE P, GUILLOU F, 2003 

Réponse immunitaire à la eCG utilisée dans le traitement de l’induction d’ovulation chez la chèvre et la brebis.

Gynecologie, Obstetrique et Fertilité, 31 :766-769.

​

​

- ROY F, COMBES M, VAIMAN D, CRIBIU EP, POBEL T, DELETANG F, COMBARNOUS Y, GUILLOU F, MAUREL MC, 1999

Humoral immune response to equine chorionic gonadotropin in ewes: association with major histocompatibility complex and interference with subsequent fertility.

Biology of Reproduction, 61, 209-218.

​

​

- ROY F, MAUREL MC, COMBES M, VAIMAN D, CRIBIU EP, LANTIER I, POBEL T, DELETANG F, COMBARNOUS Y, GUILLOU F, 1999

The negative effect of repeated equine chorionic gonadotropin treatment on subsequent fertility in alpine goats is due to humoral immune response involving the major histocompatibility complex.

Biology of Reproduction, 60, 805-813.

​

​

- CHOPINEAU M, MAUREL MC, COMBARNOUS Y, DURAND P, 1993

Topography of equine chorionic gonadotropin epitopes relative to the luteinizing hormone and follicle-stimulating hormone receptor interaction sites. 

Molecular and Cellular Endocrinology, 92, 229-239.